Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Non-Current Liabilities (2019 - 2025)

Biodesix (BDSX) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 25.28% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2025, up 25.28%, and an annual FY2025 reading of $1.0 million, up 25.28% over the prior year.
  • Other Non-Current Liabilities was $1.0 million for Q4 2025 at Biodesix, up from $769000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $30.9 million in Q1 2021 and bottomed at $70000.0 in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $7.6 million, with a median of $792000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities tumbled 99.7% in 2022, then soared 17475.71% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $16.0 million in 2021, then plummeted by 96.52% to $558000.0 in 2022, then rose by 27.6% to $712000.0 in 2023, then rose by 14.47% to $815000.0 in 2024, then increased by 25.28% to $1.0 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BDSX at $1.0 million in Q4 2025, $769000.0 in Q3 2025, and $549000.0 in Q2 2025.